SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-327235
Filing Date
2013-08-09
Accepted
2013-08-08 17:41:59
Documents
12
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d541645d10q.htm 10-Q 694060
2 EX-10.68.3 d541645dex10683.htm EX-10.68.3 35345
3 EX-31.1 d541645dex311.htm EX-31.1 10362
4 EX-31.2 d541645dex312.htm EX-31.2 10718
5 EX-32.1 d541645dex321.htm EX-32.1 4024
6 EX-32.2 d541645dex322.htm EX-32.2 4424
  Complete submission text file 0001193125-13-327235.txt   8510468

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT slxp-20130630.xml EX-101.INS 709999
8 XBRL TAXONOMY EXTENSION SCHEMA slxp-20130630.xsd EX-101.SCH 51648
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE slxp-20130630_cal.xml EX-101.CAL 57324
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE slxp-20130630_def.xml EX-101.DEF 150351
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE slxp-20130630_lab.xml EX-101.LAB 396644
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE slxp-20130630_pre.xml EX-101.PRE 260510
Mailing Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615
Business Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23265 | Film No.: 131023344
SIC: 2834 Pharmaceutical Preparations